Eton Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -12.74M-18.32M-27.97M-1.96M-9.02M-0.94M-3.82M
Depreciation and Depletion 0.05M0.15M0.07M0.04M0.05M
Share-based Compensation 1.85M1.89M2.58M3.38M4.22M3.14M3.17M
Gains from Sales and Divestitures 0.31M0.01M0.01M0.09M0.09M
Gains from Investment Securities 2.58M1.83M0.20M0.18M4.40M4.84M5.92M
Non-cash Items 0.73M11.53M2.71M3.60M51.32M
Cash from Operations -8.14M-18.03M-22.35M-4.72M4.82M6.82M0.97M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.02M0.12M0.15M0.13M0.12M0.07M
Depreciation & Amortization (CF) 0.06M0.45M0.65M0.46M1.77M0.90M1.15M
Change in Working Capital
Change in Receivables 0.47M-0.42M5.42M-3.62M1.56M3.12M
Change in Inventory 0.38M0.86M-0.69M0.01M0.35M1.31M
Change in Account Payables 0.41M-0.38M1.77M-0.57M-0.01M0.05M2.32M
Change in Accured Expenses 0.35M0.53M-0.30M0.12M1.45M2.48M1.48M
Other Working Capital Changes 0.66M1.36M0.02M1.03M-1.84M-0.09M3.35M
Investing Activities
Capital Expenditures 0.47M1.10M0.05M0.01M0.04M0.03M
Sales of Property, Plant and Equipment 0.70M
Change in Intangibles 0.75M3.25M2.75M0.78M9.99M
Acquisitions 30.00M
Cash from Investing Activities -0.24M-1.85M-0.05M-2.56M-2.79M-0.78M-40.01M
Financing Activities
Other financing activities 1.85M1.89M2.58M3.38M0.18M
Cash from Financing Activities 21.96M5.20M31.62M0.39M-0.13M-0.96M32.59M
Additional items
Change in Cash 13.58M-14.67M9.23M-6.89M1.90M5.08M-6.45M
Beginning Cash Balance -13.58M26.73M12.07M21.30M14.41M16.30M21.39M
Free Cash Flow -8.61M-19.12M-22.40M-4.73M4.78M6.82M0.94M
Net Cash Flow 13.58M-14.67M9.23M-6.89M1.90M5.08M-6.45M